Works matching AU Raje, S.


Results: 55
    1
    2
    3
    4

    Response with combined modality treatment in childhood rhabdomyosarcoma.

    Published in:
    Journal of Surgical Oncology, 1993, v. 54, n. 4, p. 243, doi. 10.1002/jso.2930540411
    By:
    • Raje, Noopur S.;
    • Rao, Suchitra R.;
    • Vaidya, Sucheta J.;
    • Shah, Rajesh V.;
    • Nair, Chandrika N.;
    • Pai, Suresh K.;
    • Kurkure, Purna A.;
    • Pande, Subodhchandra C.;
    • Desai, Prafulla B.;
    • Advani, Suresh H.
    Publication type:
    Article
    5
    6

    Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00695-5
    By:
    • Kumar, Shaji;
    • Baizer, Lawrence;
    • Callander, Natalie S.;
    • Giralt, Sergio A.;
    • Hillengass, Jens;
    • Freidlin, Boris;
    • Hoering, Antje;
    • Richardson, Paul G.;
    • Schwartz, Elena I.;
    • Reiman, Anthony;
    • Lentzsch, Suzanne;
    • McCarthy, Philip L.;
    • Jagannath, Sundar;
    • Yee, Andrew J.;
    • Little, Richard F.;
    • Raje, Noopur S.
    Publication type:
    Article
    7
    8

    Lifestyle considerations in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00560-x
    By:
    • Shapiro, Yael N.;
    • Peppercorn, Jeffrey M.;
    • Yee, Andrew J.;
    • Branagan, Andrew R.;
    • Raje, Noopur S.;
    • Donnell, Elizabeth K. O'
    Publication type:
    Article
    9
    10

    P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B‐CELL MATURATION ANTIGEN (BCMA)‐CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM‐3.

    Published in:
    HemaSphere, 2022, v. 6, p. 839, doi. 10.1097/01.HS9.0000846664.78859.dd
    By:
    • Lesokhin, A. M.;
    • Arnulf, B.;
    • Niesvizky, R.;
    • Mohty, M.;
    • Bahlis, N. J.;
    • Tomasson, M. H.;
    • Rodrίguez‐Otero, P.;
    • Quach, H.;
    • Raje, N. S.;
    • Iida, S.;
    • Raab, M.‐S.;
    • Czibere, A.;
    • Sullivan, S.;
    • Leip, E.;
    • Viqueira, A.;
    • Leleu, X.
    Publication type:
    Article
    11
    12
    13

    Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide.

    Published in:
    British Journal of Haematology, 2014, v. 166, n. 3, p. 401, doi. 10.1111/bjh.12909
    By:
    • Yee, Andrew J.;
    • Hari, Parameswaran;
    • Marcheselli, Raffaella;
    • Mahindra, Anuj K.;
    • Cirstea, Diana D.;
    • Scullen, Tyler A.;
    • Burke, Jill N.;
    • Rodig, Scott J.;
    • Hideshima, Teru;
    • Laubach, Jacob P.;
    • Ghobrial, Irene M.;
    • Schlossman, Robert L.;
    • Munshi, Nikhil C.;
    • Anderson, Kenneth C.;
    • Weller, Edie A.;
    • Richardson, Paul G.;
    • Raje, Noopur S.
    Publication type:
    Article
    14
    15
    16
    17

    A high-density intraspecific SNP linkage map of pigeonpea (Cajanas cajan L. Millsp.).

    Published in:
    PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179747
    By:
    • Arora, Sheetal;
    • Mahato, Ajay Kumar;
    • Singh, Sangeeta;
    • Mandal, Paritra;
    • Bhutani, Shefali;
    • Dutta, Sutapa;
    • Kumawat, Giriraj;
    • Singh, Bikram Pratap;
    • Chaudhary, A. K.;
    • Yadav, Rekha;
    • Gaikwad, K.;
    • Sevanthi, Amitha Mithra;
    • Datta, Subhojit;
    • Raje, Ranjeet S.;
    • Sharma, Tilak R.;
    • Singh, Nagendra Kumar
    Publication type:
    Article
    18

    Development of genic-SSR markers by deep transcriptome sequencing in pigeonpea [Cajanus cajan (L.) Millspaugh].

    Published in:
    BMC Plant Biology, 2011, v. 11, n. 1, p. 17, doi. 10.1186/1471-2229-11-17
    By:
    • Dutta, Sutapa;
    • Kumawat, Giriraj;
    • Singh, Bikram P.;
    • Gupta, Deepak K.;
    • Singh, Sangeeta;
    • Dogra, Vivek;
    • Gaikwad, Kishor;
    • Sharma, Tilak R.;
    • Raje, Ranjeet S.;
    • Bandhopadhya, Tapas K.;
    • Datta, Subhojit;
    • Singh, Mahendra N.;
    • Bashasab, Fakrudin;
    • Kulwal, Pawan;
    • Wanjari, K. B.;
    • Varshney, Rajeev K.;
    • Cook, Douglas R.;
    • Singh, Nagendra K.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 10, p. 1996, doi. 10.1002/cncr.34134
    By:
    • O'Donnell, Elizabeth K.;
    • Shapiro, Yael N.;
    • Yee, Andrew J.;
    • Nadeem, Omar;
    • Hu, Bonnie Y.;
    • Laubach, Jacob P.;
    • Branagan, Andrew R.;
    • Anderson, Kenneth C.;
    • Mo, Clifton C.;
    • Munshi, Nikhil C.;
    • Ghobrial, Irene M.;
    • Sperling, Adam S.;
    • Agyemang, Emerentia A.;
    • Burke, Jill N.;
    • Harrington, Cynthia C.;
    • Richardson, Paul G.;
    • Raje, Noopur S.;
    • El‐Jawahri, Areej
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 2, p. 222, doi. 10.1111/bjh.15261
    By:
    • O'Donnell, Elizabeth K.;
    • Laubach, Jacob P.;
    • Yee, Andrew J.;
    • Chen, Tianqi;
    • Huff, Carol Ann;
    • Basile, Frank G.;
    • Wade, Philip M.;
    • Paba‐Prada, Claudia E.;
    • Ghobrial, Irene M.;
    • Schlossman, Robert L.;
    • Burke, Jill N.;
    • Harrington, Cynthia C.;
    • Lively, Kathleen J.;
    • Lyons, Hannah F.;
    • Munshi, Nikhil C.;
    • Anderson, Kenneth C.;
    • Trippa, Lorenzo;
    • Richardson, Paul G.;
    • Raje, Noopur S.
    Publication type:
    Article
    34

    Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma.

    Published in:
    British Journal of Haematology, 2017, v. 176, n. 5, p. 783, doi. 10.1111/bjh.14483
    By:
    • Raje, Noopur S.;
    • Moreau, Philippe;
    • Terpos, Evangelos;
    • Benboubker, Lotfi;
    • Grząśko, Norbert;
    • Holstein, Sarah A.;
    • Oriol, Albert;
    • Huang, Shang‐Yi;
    • Beksac, Meral;
    • Kuliczkowski, Kazimierz;
    • Tai, Datchen F.;
    • Wooldridge, James E.;
    • Conti, Ilaria;
    • Kaiser, Christopher J.;
    • Nguyen, Tuan S.;
    • Cronier, Damien M.;
    • Palumbo, Antonio
    Publication type:
    Article
    35
    36
    37
    38
    39

    PII-33.

    Published in:
    Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P45, doi. 10.1016/j.clpt.2005.12.158
    By:
    • Raje, S. V.;
    • Parks, V.;
    • Plotka, A.;
    • Patat, A. A.;
    • Dupain, T.
    Publication type:
    Article
    40

    PIII-39.

    Published in:
    Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P68, doi. 10.1016/j.clpt.2005.12.247
    By:
    • Parks, V.;
    • Raje, S. V.;
    • Patat, A. A.;
    • Plotka, A.;
    • Astruc, B.;
    • Chassard, D.
    Publication type:
    Article
    41

    PI-34.

    Published in:
    Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P16, doi. 10.1016/j.clpt.2005.12.055
    By:
    • Patat, A. A.;
    • Raje, S. V.;
    • Langstrom, B.;
    • Parks, V.;
    • Plotka, A.;
    • Nilsson, L.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50